Europe approves Holoclar, the first stem-cell medicine
The European Commission has granted a conditional marketing authorization, under Regulation (EC) No 726/2004, to Holoclar ®, an advanced therapy based on autologous stem cells and capable to restore the eyesight of patients with severe cornea damage. Holoclar ® is manufactured by Holostem Terapie…